Search

Search Constraints

You searched for: Author/Creator van Lunzen, Jan

Search Results

1. 1021. HIV-1 RNA Blips and Low-Level Replication During Phase III/IIIb Cabotegravir + Rilpivirine Long-Acting Studies Are Similar to Oral 3-Drug Therapy and Not Associated with Week 48 Virologic Outcome. (31st December 2020)

2. Brief Report: Increased Frequency of CD39+ CD56bright Natural Killer Cells in HIV-1 Infection Correlates With Immune Activation and Disease Progression. (1st April 2017)

3. Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection. (15th April 2016)

4. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. (1st April 2018)

5. Decreased frequency of CD73+CD8+ T cells of HIV‐infected patients correlates with immune activation and T cell exhaustion. Issue 4 (1st October 2013)

6. Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients. Issue 10 (October 2014)

7. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. Issue 5 (13th February 2017)

8. Down‐regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. Issue 5 (13th February 2017)

9. Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis. (15th July 2021)

10. Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype. Issue 1 (December 2016)